- Naasan, G;
- Rabinovici, GD;
- Ghosh, P;
- Elofson, JD;
- Miller, BL;
- Coppola, G;
- Karydas, A;
- Fong, J;
- Perry, D;
- Lee, SE;
- Yokoyama, JS;
- Seeley, WW;
- Kramer, JH;
- Weiner, MW;
- Schuff, N;
- Jagust, WJ;
- Grinberg, LT;
- Pribadi, M;
- Yang, Z;
- Sears, R;
- Klein, E;
- Wojta, K;
- Rosen, HJ
Patients with frontotemporal lobar degeneration (FTLD) can show superimposed amyloid pathology, though the impact of amyloid on the clinical presentation of FTLD is not well characterized. This cross-sectional case–control study compared clinical features, fluorodeoxyglucose-positron emission tomography metabolism and gray matter volume loss in 30 patients with familial FTLD in whom amyloid status was confirmed with autopsy or Pittsburgh compound B-PET. Compared to the amyloid-negative patients, the amyloid-positive patients performed significantly worse on several cognitive tests and showed hypometabolism and volume loss in more temporoparietal regions. Our results suggest that in FTLD amyloid positivity is associated with a more Alzheimer’s disease-like pattern of neurodegeneration.